...
首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >A PRACTICAL RISK-BASED APPROACH TO ASSESS VIAL’S DIMENSIONS DEVIATIONS EFFECT ON THE ASEPTIC FILLING PROCESSING, ACCORDING TO ICH Q9 GUIDELINE
【24h】

A PRACTICAL RISK-BASED APPROACH TO ASSESS VIAL’S DIMENSIONS DEVIATIONS EFFECT ON THE ASEPTIC FILLING PROCESSING, ACCORDING TO ICH Q9 GUIDELINE

机译:根据ICH Q9指南,基于风险的实用方法来评估小瓶的尺寸偏差对无菌灌装过程的影响

获取原文

摘要

Objective: Qualitative risk assessment process is a new topic in the pharmaceutical industries. The main outcome of the risk assessment implementation is to help the manufacturers for a better decision-making, in a case that a quality problem arises. According to the ISO documents; vials used in the pharmaceutical industry have a special dimension specification and Quality Control analytical results should prove that the vial samples are in the defined range. Nevertheless, the value of these tests is not the same as defined ISO specifications; and this may have minor and/or significant impact on the final product quality. Methods: The purpose of this qualitative study was to rank the results of the vial dimention tests based on quality risk assessment. Consequently, these rankings can help to decide whether the dimension deviation from quality specification of vials is acceptable and what will be the impact of accepting the risk on the final product safety and finally how to decrease the risk. For this purpose, we consider the final product contamination could be one of the main indicators for the quality as the contamination from packaging materials in particular are more important when aseptic processing run. Results: Dimensions that are directly associated with opening the vial containing d2, d3, d4 and h4 that they affect rubber sealing and capping. Other dimensions like h1, h2, h3 and d1 affect rubber sealing and capping indirectly. Therefore, these two groups of deviations have a very high probability of contamination. Keywords: Quality Risk Assessment, Vial Dimension, Aseptic Filling Processing, ICH Q9, ISO 8362-1.
机译:目的:定性风险评估过程是制药行业的新话题。实施风险评估的主要结果是在出现质量问题的情况下帮助制造商做出更好的决策。根据ISO文件;制药行业中使用的样品瓶有特殊的尺寸规格,质量控制分析结果应证明样品瓶样品在规定的范围内。但是,这些测试的值与定义的ISO规范不同;可能会对最终产品的质量造成较小和/或重大影响。方法:本定性研究的目的是基于质量风险评估对小瓶尺寸测试的结果进行排名。因此,这些排名可以帮助确定与小瓶质量规格的尺寸偏差是否可以接受,以及接受风险对最终产品安全性的影响以及最终如何降低风险。为此,我们认为最终产品的污染可能是质量的主要指标之一,因为在无菌生产过程中,包装材料的污染尤其重要。结果:与打开含有d2,d3,d4和h4的样品瓶直接相关的尺寸会影响橡胶的密封和封盖。其他尺寸(例如h1,h2,h3和d1)会间接影响橡胶的密封和封盖。因此,这两组偏差具有很高的污染可能性。关键字:质量风险评估,样品瓶尺寸,无菌灌装工艺,ICH Q9,ISO 8362-1。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号